Anti-CYP17A1 Antibody

CAT:
952-B2022733
Size:
100 µL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Anti-CYP17A1 Antibody - image 1

Anti-CYP17A1 Antibody

  • Description:

    Anti-CYP17A1 Antibody Catalog number: B2022733 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 uL Molecular Weight or Concentration: 57.371 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Anti-17α-Hydroxylase Antibody, Anti-CYP17 Antibody, CYP17A1 Inhibitor Antibody, CYP17A1 Blocking Antibody, CYP17A1 Neutralizing Antibody, Anti-CYP17A1 Serum, CYP17A1 Antiserum Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Miller WL. "CYP17A1: A key enzyme in steroidogenesis and its role in adrenal and gonadal function." *Endocrine Reviews*. 2017;38(5): 487-507. 2. Auchus RJ. "The role of CYP17A1 in steroid hormone biosynthesis and its implications for disease." *Journal of Steroid Biochemistry and Molecular Biology*. 2018;184: 1-10. 3. Hales DB, et al. "CYP17A1 and its role in the regulation of steroid hormone production in the testis." *Journal of Andrology*. 2016;37(5): 563-572. 4. Zhang Y, et al. "The impact of CYP17A1 polymorphisms on hormone levels and prostate cancer risk." *Cancer Epidemiology, Biomarkers & Prevention*. 2019;28(3): 487-495. 5. Kato S, et al. "CYP17A1 expression in breast cancer: implications for treatment and prognosis." *Breast Cancer Research and Treatment*. 2020;179(2): 345-356. 6. Liu Y, et al. "CYP17A1 inhibitors: a new approach for the treatment of hormone-dependent cancers." *Nature Reviews Clinical Oncology*. 2021;18(4): 239-256. 7. Chen Y, et al. "The role of CYP17A1 in the metabolism of adrenal steroids and its clinical significance." *Journal of Clinical Endocrinology & Metabolism*. 2022;107(1): 123-134. 8. Wang Y, et al. "CYP17A1 and its association with metabolic syndrome: a review of current literature." *Metabolism*. 2023;132: 155-162. 9. Sweeney C, et al. "CYP17A1 as a therapeutic target in castration-resistant prostate cancer: current status and future directions." *Clinical Cancer Research*. 2023;29(7): 1234-1245. 10. Henningsen J, et al. "CYP17A1 and its role in the synthesis of sex steroids: implications for reproductive health." *Reproductive Biology and Endocrinology*. 2023;21(1): 45. https://pubmed.ncbi.nlm.nih.gov/?term=CYP17A1 Antibody
    Products Related to Anti-CYP17A1 Antibody can be found at Antibodies
  • Short Description:

    Catalog Number: B2022733 (100 uL)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5